Search for: "HOSPIRA INC."
Results 1 - 20
of 287
Sorted by Relevance
|
Sort by Date
30 Aug 2018, 9:59 pm
Hospira, Inc. [read post]
29 Nov 2020, 9:59 pm
Hospira, Inc. [read post]
28 Dec 2015, 9:59 pm
Hospira Inc. [read post]
10 Aug 2017, 9:58 pm
Hospira, Inc. answered a question that had been lingering since the very first case -- can a reference product sponsor use discovery to obtain information from a biosimilar applicant if it does not receive a copy of the aBLA or other information about the manufacturing process as required by the BPCIA? [read post]
15 Jan 2020, 9:28 pm
Hospira, Inc. [read post]
30 Oct 2017, 9:49 pm
Hospira, Inc. [read post]
5 Feb 2015, 2:02 pm
Hospira Inc., based in Lake Forest, ... [read post]
14 Jan 2020, 9:10 pm
This tendency was most recently illustrated in the Federal Circuit's decision in Hospira, Inc. v. [read post]
12 Aug 2019, 9:54 pm
Hospira, Inc. and Eli Lilly & Co. v. [read post]
10 Jan 2020, 9:15 am
The ‘106 patent, owned by Hospira, Inc. [read post]
30 Oct 2017, 9:05 pm
Hospira, Inc. v. [read post]
30 Oct 2017, 9:05 pm
Hospira, Inc. v. [read post]
9 Dec 2008, 10:58 am
Customers who have medical questions should contact Hospira Medical Communications at 1-800-615-0187. [read post]
21 Jan 2011, 9:57 am
Hospira Inc., of Lake Forest, Illinois, said Friday that its plant in Italy was the only viable place where the company could produce sodium thiopental. [read post]
19 Nov 2015, 9:17 pm
Hospira, Inc. [read post]
7 Apr 2013, 4:19 pm
Hospira, Inc. [read post]
10 Jan 2020, 9:15 am
The ‘106 patent, owned by Hospira, Inc. [read post]
29 Apr 2014, 11:54 am
Hospira, Inc. [read post]
15 Jan 2014, 7:24 am
Hospira, Inc. announced it initiated a voluntary nationwide recall to the user level for one lot of Lidocaine HCl Injection, USP, 2%, 5 mL Single-Dose Vial (NDC 0409-2066-05), Lot 32-135-DD, expiration date 1AUG2015. [read post]
9 Jan 2021, 9:16 am
Hospira, Inc. et al., Civil Action No. 20-0561-CFC (D.Del. [read post]